Literature DB >> 2047759

Serum amyloid A isoforms in inflammation.

J G Raynes1, K P McAdam.   

Abstract

Serum amyloid A protein (SAA) was extracted from serum using hydrophobic interaction chromatography and four or six isoforms were separated by isoelectric-focusing. These represented three pairs of isoforms, each with and without an N-terminal arginine. SAA1 (pI 6.1), SAA1 des-arg (pI 5.9), SAA2 alpha (pI 6.9) and SAA2 alpha des-arg (pI 6.6) were found to be present in all individuals from Europe and the USA. A minority of these individuals (11 of 56) expressed SAA2 beta (pI 7.1) and SAA2 beta des-arg (pI 6.8). Serum from patients in Papua New Guinea and Malawi both showed a much higher frequency of SAA2 beta. There was no indication of altered isoforms in regions with high incidence of reactive AA amyloidosis. In sequential serum samples, concentrations of des-arg isoforms were found to reach a maximum 0-24 h later than isoforms with an arginine. Concentrations of the isoform SAA1 decreased faster in five of six patients (16 +/- 7.5 h to decrease 50%) than SAA1 des-arg (22 +/- 11 h to decrease 50%). Variations in the handling of N-terminal arginine may be important for the formation-susceptibility of amyloid deposits.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047759     DOI: 10.1111/j.1365-3083.1991.tb02538.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.

Authors:  Gunther Marsche; Sasa Frank; John G Raynes; Karen F Kozarsky; Wolfgang Sattler; Ernst Malle
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

2.  Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.

Authors:  H Patel; J Bramall; H Waters; M C De Beer; P Woo
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

3.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

Authors:  R L Meek; S Urieli-Shoval; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

4.  Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors.

Authors:  Karin Christenson; Lena Björkman; Sofie Ahlin; Maja Olsson; Kajsa Sjöholm; Anna Karlsson; Johan Bylund
Journal:  Front Immunol       Date:  2013-04-22       Impact factor: 7.561

5.  Serum amyloid a truncations in type 2 diabetes mellitus.

Authors:  Hussein N Yassine; Olgica Trenchevska; Huijuan He; Chad R Borges; Dobrin Nedelkov; Wendy Mack; Naoko Kono; Juraj Koska; Peter D Reaven; Randall W Nelson
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

Review 6.  Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Proteomes       Date:  2016-03-17

7.  Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein.

Authors:  Megumi Sato; Ryunosuke Ohkawa; Akira Yoshimoto; Kouji Yano; Naoya Ichimura; Madoka Nishimori; Shigeo Okubo; Yutaka Yatomi; Minoru Tozuka
Journal:  Biosci Rep       Date:  2016-08-16       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.